Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
20,040,765
-
Shares change
-
+3,926,307
-
Total reported value, excl. options
-
$281,768,540
-
Value change
-
+$49,654,282
-
Put/Call ratio
-
176%
-
Number of buys
-
49
-
Number of sells
-
24
-
Price
-
$14.06
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2015
As of 30 Sep 2015 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,040,765 shares of stock of the company.
Largest 10 holders included FMR LLC, Capital Research Global Investors, Versant Venture Management, LLC, Capital World Investors, FEDERATED INVESTORS INC /PA/, Lamond Capital Partners LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, and Portolan Capital Management, LLC.
This table shows 66 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.